Yu-min Li
Impact in
- Epidemiology top 0.5%
- Autophagy in Disease and Therapy
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
-
- MicroRNA in disease regulation 20
- Oncology 43
- Pancreatic and Hepatic Oncology Research 10
- CAR-T cell therapy research 10
- Co-authors
- Lele Miao (13 shared papers)Zhengchao Zhang (12 shared papers)Hao Chen (8 shared papers)Zhi‐Jian Han (3 shared papers)Zhijian Ren (13 shared papers)Heshui Shi (17 shared papers)Futian Tang (19 shared papers)Xiaoyu Han (16 shared papers)
- Journals
- Frontiers in Oncology (12 papers)Scientific Reports (9 papers)Frontiers in Immunology (8 papers)International Journal of Oncology (5 papers)Medicine (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yu-min Li
302 papers receiving 10.9k citations
Yu-min Li's Hit Papers
Peers
Comparison fields: 5 of 151
- Epidemiology 2.8k
- Cancer Research 872
- Oncology 1.2k
- Aging 70
- Neurology 495
Countries citing papers authored by Yu-min Li
This map shows the geographic impact of Yu-min Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-min Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-min Li more than expected).
Fields of papers citing papers by Yu-min Li
This network shows the impact of papers produced by Yu-min Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-min Li. The network helps show where Yu-min Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu-min Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 317 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Hit paper breakdown → | 2016 | 4680 |
| 2 | Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia Hit paper breakdown → | 2021 | 450 |
| 3 | 2018 | 285 | |
| 4 | 2017 | 165 | |
| 5 | 2018 | 137 | |
| 6 | 2010 | 132 | |
| 7 | 2010 | 127 | |
| 8 | 2022 | 105 | |
| 9 | 2021 | 96 | |
| 10 | 2022 | 90 | |
| 11 | 2010 | 89 | |
| 12 | 2019 | 88 | |
| 13 | 2019 | 87 | |
| 14 | Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies. | 2019 | 78 |
| 15 | 2020 | 73 | |
| 16 | 2018 | 72 | |
| 17 | 2021 | 70 | |
| 18 | 2010 | 68 | |
| 19 | 2012 | 63 | |
| 20 | 2021 | 63 |
About Yu-min Li
Yu-min Li is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 317 papers that have together received 11.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (41 papers), Helicobacter pylori-related gastroenterology studies (27 papers), MicroRNA in disease regulation (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Pancreatic and Hepatic Oncology Research (10 papers), CAR-T cell therapy research (10 papers), Sepsis Diagnosis and Treatment (8 papers) and Retinal and Macular Surgery (7 papers). The work is most often cited by research in Epidemiology (2.8k citations), Cancer Research (872 citations), Oncology (1.2k citations), Aging (70 citations) and Neurology (495 citations). Yu-min Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lele Miao, Zhengchao Zhang, Hao Chen, Zhi‐Jian Han, Zhijian Ren, Heshui Shi, Futian Tang, Xiaoyu Han, Xuejiao Zhu and Yukun Cao. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Frontiers in Immunology, International Journal of Oncology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.